scholarly article | Q13442814 |
P356 | DOI | 10.1210/ENDO.140.7.6769 |
P698 | PubMed publication ID | 10385425 |
P2093 | author name string | Krueger RG | |
Yeap BB | |||
Leedman PJ | |||
P433 | issue | 7 | |
P1104 | number of pages | 10 | |
P304 | page(s) | 3282-3291 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Endocrinology | Q3054009 |
P1476 | title | Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells | |
P478 | volume | 140 |
Q36911639 | A Role for Androgens in Epithelial Proliferation and Formation of Glands in the Mouse Uterus |
Q35738910 | A study of the prostate, androgens and sexual activity of male rats |
Q37091948 | ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin. |
Q39124868 | AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo |
Q24815477 | Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation |
Q57825403 | Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells |
Q37587750 | Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer. |
Q38976815 | Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells |
Q37050377 | Androgen receptor drives transcription of rat PACAP in gonadotrope cells |
Q37212287 | Androgen signaling disruption during fetal and postnatal development affects androgen receptor and connexin 43 expression and distribution in adult boar prostate |
Q36766910 | Androgen therapy and atherosclerotic cardiovascular disease. |
Q90356412 | Androgenic modulation of AR-Vs |
Q47128016 | Busulfan administration produces toxic effects on epididymal morphology and inhibits the expression of ZO-1 and vimentin in the mouse epididymis |
Q34995845 | Dietary lignan intake and androgen receptor expression in breast tumors |
Q34278212 | Differential hormonal regulation of estrogen receptors ERalpha and ERbeta and androgen receptor expression in rat efferent ductules. |
Q42911316 | Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders |
Q44450921 | Estradiol and a selective estrogen receptor modulator affect steroid hormone receptor messenger RNA levels and turnover in explant cultures of sheep endometrium |
Q37139070 | Experimental evidence of persistent androgen-receptor-dependency in castration-resistant prostate cancer |
Q33880106 | Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms |
Q36474388 | Expression of estrogen receptor beta in human colorectal cancer. |
Q39853440 | Expression, regulation and function of the ISGylation system in prostate cancer |
Q33967590 | Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins |
Q34122589 | Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element |
Q58772565 | Inhibition of histamine receptor H3R suppresses prostate cancer growth, invasion and increases apoptosis via the AR pathway |
Q50234048 | Interrelation of androgen receptor and miR-30a and miR-30a function in ER-, PR-, AR+ MDA-MB-453 breast cancer cells |
Q34162276 | MRNA stability and the control of gene expression: implications for human disease |
Q37018606 | NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. |
Q36471379 | Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability |
Q27335274 | Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment |
Q33922404 | Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer |
Q36129336 | Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor. |
Q39757062 | Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells |
Q88499304 | Role of HPA and the HPG Axis Interaction in Testosterone-Mediated Learned Helpless Behavior |
Q61816260 | Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes |
Q91993029 | Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus |
Q38354101 | Systematic identification of transcription factors associated with patient survival in cancers |
Q33911291 | The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation |
Q33569562 | The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium |
Q21195890 | The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice |
Q81580780 | The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth |
Q39628604 | The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression |
Q30308224 | Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression |
Q40274276 | c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation |
Search more.